Study guide
Pregnancy hypertension and preeclampsia
AMC CAT MCQ Examination AMC Part 1
Track your progress as you read
Finished sections get a check mark.
1 Acute Coronary Syndromes & ECG Localization
ACS recognition and ECG localisation Reperfusion and infarction complications
2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias
Heart failure assessment and treatment Arrhythmias and conduction emergencies
3 Systemic Hypertension & Peripheral Vascular Disease
Blood pressure and cardiovascular risk Secondary hypertension and arterial disease
4 Valvular Heart Disease, Infective Endocarditis & Pericarditis
Aortic and mitral valve disease Endocarditis and pericardial emergencies
5 Asthma & COPD Acute Flares and Maintenance
Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations
6 Pneumonia, pleural disease and respiratory failure
Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis
7 GI bleeding, bowel inflammation and malabsorption
GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS
8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis
Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance
9 Diabetes, thyroid and adrenal disease
Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease
10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies
AKI and chronic kidney disease Potassium and sodium emergencies
11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment
Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care
12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis
Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia
13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology
Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms
14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis
Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment
15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries
Trauma primary survey and adjuncts Chest trauma and immediate threats
16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance
Head injury, imaging and haemorrhage Herniation and spinal cord injury
17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome
Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury
18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care
Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus
19 Aortic Aneurysms & Acute Arterial Limb Ischaemia
Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia
20 Urological Emergencies, Testicular Torsion & Haematuria Investigation
Retention, stones and obstructed infection Scrotal pain and haematuria
21 Preoperative Risk Stratification & Postoperative Surgical Complications
Preoperative assessment and medicines Postoperative complications and prevention
22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening
Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons
23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy
Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding
24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies
Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth
25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis
Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care
26 Contraception, Emergency Contraception & Pregnancy Termination
Contraceptive choice and missed pills Emergency contraception and abortion
27 Australian Cervical Screening Program & Gynaecological Malignancies
Cervical screening and cervical cancer Endometrial and ovarian cancer
28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice
Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening
29 Developmental Milestones, Growth Charts & Failure to Thrive
Developmental milestones Regression, autism and support Faltering growth and developmental comparisons
30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions
Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons
31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis
Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis
32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease
Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up
33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury
Pyloric stenosis Intussusception and dehydration Child protection and injury assessment
34 The Mental State Examination & Suicide Risk Stratification
Mental state examination and psychotic symptoms Suicide formulation and mental health law
35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers
Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT
36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder
Anxiety, panic and agoraphobia OCD and trauma-related disorders
37 Schizophrenia, Acute Psychosis & Antipsychotic Management
Psychosis assessment and antipsychotics Clozapine and severe adverse effects
38 Substance Use Disorders & Acute Withdrawal Syndromes
Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants
39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry
Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry
40 Medicare, PBS, AHPRA & Good Medical Practice Framework
Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications
41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment
Consent, material risks and young people Capacity, refusal and substitute decisions
42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications
Privacy, disclosure and child reporting Driving fitness and threat disclosure
43 First Nations health and preventive care
First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention
44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases
Epidemiology, calculations, bias and surveillance
45 Neurological presentations
Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness
46 Musculoskeletal pain
Back, neck, bone and soft tissue pain
47 Eye presentations
Altered vision and retinal disease Red eye, ocular injury and discharge
48 Ear, nose, throat and oral health
Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis
49 Skin, hair and nails
Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities
50 Breast health and feeding
Breast lumps, discharge and breastfeeding problems
51 Sexual and reproductive presentations
Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction
52 Palliative care and carers
The dying patient, symptoms and carers
53 Eating disorders and personality care
Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care
54 Sleep presentations
Insomnia, snoring and daytime sleepiness
55 Poisoning, resuscitation and environmental emergencies
Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning
56 Communication, rights and professional practice
Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health
57 Genetics, research and donation
Genetic testing, research and organ donation
58 Travel, fever and outbreaks
Fever, travellers and outbreak response
Pregnancy hypertension and preeclampsia
Key Takeaways Explain This Topic AI
Severe hypertension is systolic at least 160 or diastolic at least 110 mmHg.
Preeclampsia assessment includes platelets, renal function and liver involvement.
Maternal stabilisation and fetal assessment guide timing of delivery.
Last updated: October 2026
Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy
Hypertensive disorders complicate up to 10% of all pregnancies in Australia and represent a leading cause of maternal and perinatal morbidity and mortality. Accurate classification, recognition of multi-organ involvement, protocolized management of eclampsia, and rapid differentiation of antepartum haemorrhage are essential core competencies.
Classification of Hypertensive Disorders in Pregnancy
The Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) categorizes hypertensive disorders of pregnancy into four distinct clinical entities:
Chronic Hypertension : Hypertension confirmed prior to conception or documented before 20 + 0 20^{+0} 2 0 + 0 weeks gestation, or persisting > 12 weeks > 12\text{ weeks} > 12 weeks postpartum. May be primary (essential, ~90%) or secondary (renal parenchymal disease, renal artery stenosis, endocrine disease).
Gestational Hypertension : New-onset hypertension arising at or after 20 + 0 20^{+0} 2 0 + 0 weeks gestation with systolic BP ≥ 140 mmHg \text{BP} \ge 140\text{ mmHg} BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg \text{BP} \ge 90\text{ mmHg} BP ≥ 90 mmHg , in the complete absence of proteinuria or signs of maternal organ dysfunction. Blood pressure typically normalizes within 12 weeks postpartum. Approximately 25% of women with gestational hypertension will subsequently develop pre-eclampsia.
Pre-eclampsia : A multi-system endothelial disorder characterized by new-onset hypertension arising at or after 20 + 0 20^{+0} 2 0 + 0 weeks gestation accompanied by either proteinuria OR evidence of maternal organ dysfunction :
Proteinuria : Documented by a spot urine protein-to-creatinine ratio (PCR) ≥ 30 mg/mmol \ge 30\text{ mg/mmol} ≥ 30 mg/mmol , spot albumin-to-creatinine ratio (ACR) ≥ 8 mg/mmol \ge 8\text{ mg/mmol} ≥ 8 mg/mmol , or 24-hour urine total protein ≥ 300 mg \ge 300\text{ mg} ≥ 300 mg .
Maternal Organ Dysfunction (diagnostic of pre-eclampsia even in the absence of proteinuria):
Renal : Serum creatinine ≥ 90 mcmol/L \ge 90\text{ mcmol/L} ≥ 90 mcmol/L or doubling of baseline serum creatinine.
Maternal haematological dysfunction: Platelets below 150 × 10^9/L can meet the SOMANZ preeclampsia criterion. HELLP commonly uses below 100 alongside haemolysis and liver abnormalities; these are different thresholds.
Hepatic : Serum transaminases (ALT or AST) elevated > 2 × > 2 \times > 2 × the upper limit of normal, or severe, persistent epigastric or right upper quadrant abdominal pain (reflecting hepatic capsule distension / subcapsular haematoma).
Neurological : Severe, intractable frontal/occipital headache, visual disturbances (photopsia, scotomata, diplopia, cortical blindness), hyperreflexia with sustained clonus ( ≥ 3 beats \ge 3\text{ beats} ≥ 3 beats ), or altered mental status.
Cardiorespiratory : Acute pulmonary oedema.
Fetal-Placental : Fetal growth restriction (estimated fetal weight < 10 th < 10\text{th} < 10 th percentile), abnormal umbilical artery Doppler velocimetry (absent or reversed end-diastolic velocity), or oligohydramnios.
Pre-eclampsia Superimposed on Chronic Hypertension : Development of new-onset proteinuria, sudden acceleration of blood pressure, or maternal organ dysfunction after 20 weeks gestation in a woman with pre-existing chronic hypertension.
Prevention in High-Risk Women
Women identified at high risk for pre-eclampsia (previous pre-eclampsia, chronic hypertension, pre-existing type 1 or 2 diabetes, chronic kidney disease, antiphospholipid syndrome, or multiple gestation) should be prescribed low-dose aspirin ( 100 to 150 mg 100\text{ to }150\text{ mg} 100 to 150 mg nocte) commencing between 12 and 16 weeks gestation and continued until 36 weeks. Aspirin selectively inhibits platelet thromboxane A2 production, promoting uteroplacental vascular remodeling.
Antihypertensive Management
Antihypertensive therapy is indicated to reduce maternal cerebrovascular haemorrhage and cardiovascular events. The Australian target blood pressure is systolic 110 – 135 mmHg 110\text{–}135\text{ mmHg} 110 – 135 mmHg and diastolic 70 – 85 mmHg 70\text{–}85\text{ mmHg} 70 – 85 mmHg :
First-Line Oral Agents :
Labetalol : Combined alpha- and beta-blocker ( 100 – 400 mg 100\text{–}400\text{ mg} 100 – 400 mg bd/tds). First-line in Australia. Avoid in women with severe asthma.
Nifedipine (Sustained-Release) : Dihydropyridine calcium channel blocker ( 20 – 60 mg 20\text{–}60\text{ mg} 20 – 60 mg daily or bd). Safe and effective; avoid sublingual immediate-release capsules due to risk of sudden, uncontrolled hypotension.
Methyldopa : Centrally acting alpha-2 agonist ( 250 – 750 mg 250\text{–}750\text{ mg} 250 – 750 mg tds). Long safety record, but slow onset and carries risks of sedation, depression, and postpartum mood disturbance.
Severe hypertension in pregnancy: Systolic pressure at least 160 OR diastolic at least 110 mmHg requires urgent confirmation, treatment and obstetric review. Do not require both values to be elevated. Watch for headache, visual disturbance, epigastric pain and organ dysfunction.
Intravenous Labetalol : 20 – 50 mg 20\text{–}50\text{ mg} 20 – 50 mg IV bolus over 2 minutes, repeatable at 10- to 15-minute intervals up to a maximum cumulative dose of 200 mg 200\text{ mg} 200 mg , or maintenance IV infusion ( 20 – 160 mg/hour 20\text{–}160\text{ mg/hour} 20 – 160 mg/hour ).
Oral Immediate-Release Nifedipine : 10 mg 10\text{ mg} 10 mg tablet swallowed (not bitten or chewed), repeatable after 30 minutes if needed.
Intravenous Hydralazine : 5 – 10 mg 5\text{–}10\text{ mg} 5 – 10 mg slow IV bolus over 20 minutes, repeatable every 20 minutes up to 20 mg 20\text{ mg} 20 mg , followed by infusion ( 1.5 – 5 mg/hour 1.5\text{–}5\text{ mg/hour} 1.5 – 5 mg/hour ). Frequently causes reflex maternal tachycardia and headache.
Strictly Contraindicated Antihypertensives : Angiotensin-Converting Enzyme (ACE) inhibitors, Angiotensin II Receptor Blockers (ARBs), and direct renin inhibitors are strictly contraindicated throughout pregnancy due to severe fetotoxicity (oligohydramnios, renal dysgenesis, pulmonary hypoplasia, neonatal renal failure, and calvarial hypoplasia).
Delivery Timing in Pre-eclampsia
Delivery is the only definitive curative therapy for pre-eclampsia:
Gestational age ≥ 37 + 0 \ge 37^{+0} ≥ 3 7 + 0 weeks : Planned delivery is indicated regardless of severity.
Gestational age < 34 + 0 < 34^{+0} < 3 4 + 0 weeks : Expectant management under strict maternal-fetal inpatient surveillance is attempted if both mother and fetus remain stable. Betamethasone (11.4 mg IM, two doses 24 hours apart) is administered to accelerate fetal surfactant production. Indications for immediate delivery at any gestational age include uncontrollable severe hypertension, eclampsia, pulmonary oedema, platelet count < 50 × 10 9 /L < 50 \times 10^9\text{/L} < 50 × 1 0 9 /L , deteriorating renal/liver function, placental abruption, or non-reassuring fetal status.
Primary references (checked 7 October 2026): Queensland maternity guidelines .